Stock Market Crash: 3 High-Yielding Dividend Stocks Near Their 52-Week Lows to Buy Right NowThe Motley Fool • 04/30/25
Merck to invest $1B in new US plant to make blockbuster cancer treatment KeytrudaNew York Post • 04/29/25
Merck Breaks Ground on New $1 Billion Biologics Center of Excellence in Wilmington, DelawareBusiness Wire • 04/29/25
Merck to invest $1 billion in new Delaware plant to boost US manufacturing, WSJ reportsReuters • 04/29/25
Merck will build a $1 billion plant to expand U.S. manufacturing as tariff threats loomWSJ • 04/29/25
KEYTRUDA® (pembrolizumab) as Perioperative Treatment With Standard of Care (SOC) Adjuvant Therapy Significantly Improved Event-Free Survival Compared to SOC Alone in Patients With Resectable Locally Advanced Head and Neck Squamous Cell CarcinomaBusiness Wire • 04/27/25
Merck absorbs $200 million in tariff costs into its earnings and full-year outlookMarket Watch • 04/24/25
Gardasil Sales Decline — Again. Can Dow Jones Stock Merck Take The Hit?Investors Business Daily • 04/24/25
Merck Stock Slumps Ahead Of Q1 Earnings: Can Bulls Find Relief In Buying Pressure?Benzinga • 04/23/25
Will These 5 Large Drug Maker Stocks Surpass Q1 Earnings Forecast?Zacks Investment Research • 04/22/25